Skip to content
  • Home
  • About
  • Contact
  • Services
  • Advertise with Us
US Pharma Marketing Logo

US Pharma Marketing

  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A

Industry Landscape

Articles under this category focus on macro trends, big pharma behavior, and annual outlooks.

AI-Driven Personalization in Pharma Marketing: Building Trust Through Data and Responsiveness
Posted in
  • Digital Transformation
  • Industry Landscape

AI-Driven Personalization in Pharma Marketing: Building Trust Through Data and Responsiveness

Walk into any discussion with senior leaders in pharma today, and one theme dominates the room: … AI-Driven Personalization in Pharma Marketing: Building Trust Through Data and ResponsivenessRead more

by Gurinder Khera•September 29, 2025September 29, 2025•0
Europe and U.K. Ignite a New Era of Talent Magnetism: How Financial Incentives Draw U.S. Scientists Abroad
Posted in
  • Industry Landscape
  • Strategy & Execution

Europe and U.K. Ignite a New Era of Talent Magnetism: How Financial Incentives Draw U.S. Scientists Abroad

When you glance at job boards for life-science positions, you’ll notice something shifting—not a trickle, but … Europe and U.K. Ignite a New Era of Talent Magnetism: How Financial Incentives Draw U.S. Scientists AbroadRead more

by Gurinder Khera•September 24, 2025September 24, 2025•0
How Pharma Must Reimagine Its Role in the $1 Trillion Healthcare Reinvention
Posted in
  • Case Studies & Trends
  • Digital Transformation
  • Industry Landscape

How Pharma Must Reimagine Its Role in the $1 Trillion Healthcare Reinvention

Imagine waking up five years from now and realizing that the pharmaceutical industry you thought you … How Pharma Must Reimagine Its Role in the $1 Trillion Healthcare ReinventionRead more

by Gurinder Khera•September 24, 2025September 24, 2025•0
How Agentic AI Is Redefining Pharma Clinical Trials: A Deep Dive into Medable’s Approach and the Road Ahead
Posted in
  • Industry Landscape
  • Regulatory Compliance
  • Strategy & Execution

How Agentic AI Is Redefining Pharma Clinical Trials: A Deep Dive into Medable’s Approach and the Road Ahead

Why do clinical trials—arguably the most critical phase of drug development—still depend on outdated, manual oversight? … How Agentic AI Is Redefining Pharma Clinical Trials: A Deep Dive into Medable’s Approach and the Road AheadRead more

by Gurinder Khera•September 24, 2025September 24, 2025•0
How Pharma Marketers Are Harnessing AI for Content Efficiency — And Navigating the Risks
Posted in
  • Digital Transformation
  • Industry Landscape

How Pharma Marketers Are Harnessing AI for Content Efficiency — And Navigating the Risks

The pace of pharma marketing has never been more unforgiving. Content demands are multiplying across channels, … How Pharma Marketers Are Harnessing AI for Content Efficiency — And Navigating the RisksRead more

by Gurinder Khera•September 24, 2025September 24, 2025•0
How AI is Transforming Drug Discovery: A Look at Immunai’s Partnership with Pfizer and Novo Nordisk
Posted in
  • Digital Transformation
  • Industry Landscape
  • Regulatory Compliance

How AI is Transforming Drug Discovery: A Look at Immunai’s Partnership with Pfizer and Novo Nordisk

In recent years, artificial intelligence (AI) has moved from the realm of speculative fiction into a … How AI is Transforming Drug Discovery: A Look at Immunai’s Partnership with Pfizer and Novo NordiskRead more

by Gurinder Khera•September 16, 2025September 16, 2025•0
The State of COVID-19 Vaccines in 2025: What You Need to Know
Posted in
  • Case Studies & Trends
  • Industry Landscape

The State of COVID-19 Vaccines in 2025: What You Need to Know

By 2025, COVID-19 vaccines have undergone a significant evolution since the first doses were administered in … The State of COVID-19 Vaccines in 2025: What You Need to KnowRead more

by Gurinder Khera•September 16, 2025September 16, 2025•0
China’s Biotech Landscape: The Booming World of Drug Licensing Deals and Pipeline Opportunities
Posted in
  • Case Studies & Trends
  • Digital Transformation
  • Industry Landscape

China’s Biotech Landscape: The Booming World of Drug Licensing Deals and Pipeline Opportunities

China’s biotech sector is undergoing a significant transformation. With a growing number of biotech companies, drug … China’s Biotech Landscape: The Booming World of Drug Licensing Deals and Pipeline OpportunitiesRead more

by Gurinder Khera•September 16, 2025September 16, 2025•0
Exiting Stealth: What You Need to Know When Marketing Your Biotech
Posted in
  • Case Studies & Trends
  • Digital Transformation
  • Industry Landscape

Exiting Stealth: What You Need to Know When Marketing Your Biotech

The biotech industry is a unique space where cutting-edge innovation meets strict regulatory oversight, making marketing … Exiting Stealth: What You Need to Know When Marketing Your BiotechRead more

by Gurinder Khera•September 16, 2025September 16, 2025•0
Why Emotional Intelligence Beats Cold Calls in Pharma Sales
Posted in
  • Industry Landscape

Why Emotional Intelligence Beats Cold Calls in Pharma Sales

Discover how emotional intelligence drives pharma sales success. Learn smart strategies to boost trust, empathy, and … Why Emotional Intelligence Beats Cold Calls in Pharma SalesRead more

by Medha Kanaparthy•September 13, 2025September 13, 2025•0

Posts pagination

Previous 1 … 14 15 16 … 19 Next

Recent Posts

  • HIPAA Compliance in Pharmaceutical Marketing
  • FDA Promotional Guidelines for Pharma Marketing 2026
  • Cross-Selling Techniques for Pharma Sales Reps
  • How to Use Patient Assistance Programs in Your Sales Strategy
  • Selling to Nurse Practitioners and Physician Assistants

Recent Comments

No comments to show.
Copyright © 2026 US Pharma Marketing.
Powered by WordPress and HybridMag.
  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A